Canopy Growth Corp

CGC ·Healthcare, Drug Manufacturers - General, Ontario, Canada
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2018
Operating Activities
Net Income $-51.1M
Depreciation & Amortization
Depreciation $8.7M
Amortization $11.8M
Stock-Based Compensation $49.1M
Net Cash from Operating Activities $-81.5M
Investing Activities
Capital Expenditures $176.0M
Business Acquisitions
Net Cash from Investing Activities $-223.6M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $525.8M
Net Change in Cash $220.8M
Free Cash Flow $-257.5M
← Newer Page 2 of 2 Older →